Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.48 |
| ▸ | TMPRSS6 | Q8IU80 | 5/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.45 |
| ▸ | ST14 | Q9Y5Y6 | 7/20 | 0.44 |
| ▸ | F10 | P00742 | 6/20 | 0.44 |
| ▸ | PLG | P00747 | 3/20 | 0.44 |
| ▸ | PLAU | P00749 | 3/20 | 0.44 |
| ▸ | CTSL | P07711 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | CTSK | P43235 | 3/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16459579 | 0.86 | CTSL (0.43) | F2TMPRSS6NPY5RST14F10 | |
| SCHEMBL12225587 | 0.84 | PSMB5 (0.51) | F2TMPRSS6NPY5RCTSLCTSS | |
| SCHEMBL19387801 | 0.83 | PSMB5 (0.45) | F2TMPRSS6ST14F10PLG | |
| SCHEMBL3148761 | 0.81 | PSMB5 (0.54) | F2TMPRSS6CTSLCTSSCTSK | |
| SCHEMBL16458817 | 0.78 | ALDH1A1 (0.47) | F2TMPRSS6NPY5RBCHEUSP30 | |
| SCHEMBL16459016 | 0.77 | NPY5R (0.50) | F2NPY5RST14F10PLG | |
| SCHEMBL16458895 | 0.76 | ALDH1A1 (0.48) | F2TMPRSS6NPY5RBCHE | |
| SCHEMBL16458535 | 0.75 | ALDH1A1 (0.52) | F2TMPRSS6NPY5RBCHEUSP30 | |
| SCHEMBL16457747 | 0.73 | NPY5R (0.47) | F2TMPRSS6NPY5RST14F10 | |
| SCHEMBL16459056 | 0.72 | ALDH1A1 (0.48) | F2TMPRSS6NPY5RBCHEUSP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140011998-A1 | DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011998-A1 | DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID | PSMB6, PSMB5, PSMB1 | F2 4784/4885TMPRSS6 1692/4885NPY5R 4010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.